PMID- 1905642 OWN - NLM STAT- MEDLINE DCOM- 19910805 LR - 20081121 IS - 0014-2980 (Print) IS - 0014-2980 (Linking) VI - 21 IP - 7 DP - 1991 Jul TI - Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4. PG - 1669-75 AB - Tumor necrosis factor-alpha (TNF-alpha) strongly activates murine peritoneal macrophages (M phi) for killing of amastigotes from Leishmania major in the presence of low amounts of interferon-gamma (IFN-gamma). Recently, we found that IFN-gamma and interleukin 4 (IL 4) also synergistically enhance the antileishmanial potential of M phi. In this report, evidence is provided that the synergism of IFN-gamma and IL 4 is based on the ability of the lymphokines to induce the endogenous production of TNF-alpha. First, both IFN-gamma and IL 4 as single agents and in combination were potent inducers of TNF-alpha production by M phi infected with L. major amastigotes. Second, the synergistic effect of IFN-gamma and IL 4 on parasite killing by M phi strongly correlated with their synergistic effect on the release of TNF-alpha. Third, the IFN-gamma/IL 4-mediated parasite elimination was completely abrogated not only in the presence of antibodies to IFN-gamma and IL 4, but also with an antibody specific for TNF-alpha. Consistent with the conclusion that endogenously produced TNF-alpha accounts for the synergism of IL 4 with IFN-gamma is the finding that N omega-monomethyl-L-arginine, an inhibitor of the L-arginine-dependent generation of microbicidal nitrogen intermediates, totally blocked the M phi activation induced by IFN-gamma combined with IL 4 as well as by IFN-gamma combined with TNF-alpha. These results underline the complex interplay of cytokines derived from lymphocytes and M phi and the role of TNF-alpha as pivotal factor for the induction of antileishmanial effector functions. FAU - Stenger, S AU - Stenger S AD - Institute of Clinical Microbiology, University of Erlangen, FRG. FAU - Solbach, W AU - Solbach W FAU - Rollinghoff, M AU - Rollinghoff M FAU - Bogdan, C AU - Bogdan C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Germany TA - Eur J Immunol JT - European journal of immunology JID - 1273201 RN - 0 (Lipopolysaccharides) RN - 0 (Tumor Necrosis Factor-alpha) RN - 207137-56-2 (Interleukin-4) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Drug Synergism MH - Female MH - Interferon-gamma/*pharmacology MH - Interleukin-4/*pharmacology MH - Leishmania tropica/*drug effects MH - Leishmaniasis/metabolism/therapy MH - Lipopolysaccharides/pharmacology MH - Macrophages/*metabolism MH - Mice MH - Mice, Inbred BALB C MH - Tumor Necrosis Factor-alpha/*biosynthesis EDAT- 1991/07/01 00:00 MHDA- 1991/07/01 00:01 CRDT- 1991/07/01 00:00 PHST- 1991/07/01 00:00 [pubmed] PHST- 1991/07/01 00:01 [medline] PHST- 1991/07/01 00:00 [entrez] AID - 10.1002/eji.1830210713 [doi] PST - ppublish SO - Eur J Immunol. 1991 Jul;21(7):1669-75. doi: 10.1002/eji.1830210713.